Cytodyn Inc (CYDY)

[Borel Fields]

Here's the precise reality of the UCLA EIND experience - not quite as rosy as painted.

At 7:46 in the June 2nd presentation, NP shows a slide of the results of 31 patients at UCLA:

11 critical: 4 extubated and discharged, 4 stable, 3 deceased

20 severe: 15 discharged, 1 improved, still hospitalized, 1 too early, 3 deceased.

Hopefully, the trial-enrolled patients are healthier, or were treated more knowledgeably than the earlier ones. But our trial has few exclusions - it's truly the "trial of the sickest."

We have to be mentally prepared to see a lot of deaths in both arms of the severe/critical trial.